Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Cancers
|
November 27, 2024
Delayed and Concurrent Stereotactic Radiosurgery in Immunotherapy-Naïve Melanoma Brain Metastases
Christine E Hadley, Jennifer K Matsui, Dukagjin M Blakaj, et al.
Cancer Growth and Metastasis
|
December 10, 2015
Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma
Arabinda Das, Ron Ron Cheng, Megan L T Hilbert, et al.
Journal of Neuro-Oncology
|
December 12, 2025
Management of intermediate-sized brain metastases of the primary motor cortex
Mark A Damante, Guilherme Finger, Ryan B Juncker, et al.
Neuro-Oncology
|
August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
Mark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
Research Square
|
May 3, 2023
Unsupervised machine learning models reveal predictive markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation
Wesley Wang, Zeynep Temerit Kumm, Cindy Ho, et al.
Journal of Neurology and Neurosurgery
|
October 28, 2014
Current Studies of Immunotherapy on Glioblastoma
Neena Stephanie Agrawal, Rickey Miller, Richa Lal, et al.
Cancer Research Communications
|
March 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent <i>IDH1-</i> and <i>IDH2</i>-mutant Glioma
Kristina Fanucci, Mary Jo Pilat, Derek Shyr, et al.
International Journal of Molecular Sciences
|
March 28, 2026
Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review
Tugce Kutuk, Ece Atak, Marshall Harrell, et al.
Cancer
|
November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
Pierre Giglio, Megha Dhamne, Kenneth R Hess, et al.
Neuro-Oncology Advances
|
February 26, 2024
Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation
Wesley Wang, Zeynep Temerit Kumm, Cindy Ho, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Cancers
|
November 27, 2024
Delayed and Concurrent Stereotactic Radiosurgery in Immunotherapy-Naïve Melanoma Brain Metastases
Christine E Hadley, Jennifer K Matsui, Dukagjin M Blakaj, et al.
Cancer Growth and Metastasis
|
December 10, 2015
Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma
Arabinda Das, Ron Ron Cheng, Megan L T Hilbert, et al.
Journal of Neuro-Oncology
|
December 12, 2025
Management of intermediate-sized brain metastases of the primary motor cortex
Mark A Damante, Guilherme Finger, Ryan B Juncker, et al.
Neuro-Oncology
|
August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
Mark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
Research Square
|
May 3, 2023
Unsupervised machine learning models reveal predictive markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation
Wesley Wang, Zeynep Temerit Kumm, Cindy Ho, et al.
Journal of Neurology and Neurosurgery
|
October 28, 2014
Current Studies of Immunotherapy on Glioblastoma
Neena Stephanie Agrawal, Rickey Miller, Richa Lal, et al.
Cancer Research Communications
|
March 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent <i>IDH1-</i> and <i>IDH2</i>-mutant Glioma
Kristina Fanucci, Mary Jo Pilat, Derek Shyr, et al.
International Journal of Molecular Sciences
|
March 28, 2026
Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review
Tugce Kutuk, Ece Atak, Marshall Harrell, et al.
Cancer
|
November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
Pierre Giglio, Megha Dhamne, Kenneth R Hess, et al.
Neuro-Oncology Advances
|
February 26, 2024
Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation
Wesley Wang, Zeynep Temerit Kumm, Cindy Ho, et al.
Page
of 10